Kfar Bilu, Israel

Ofer Lider


Average Co-Inventor Count = 4.1

ph-index = 6

Forward Citations = 100(Granted Patents)


Location History:

  • Herzliya, IL (1995)
  • Kfar Bilu Bet, IL (2005 - 2007)
  • Rehovot, IL (1996 - 2008)
  • Kfar Bilu B, IL (2014)

Company Filing History:


Years Active: 1995-2014

Loading Chart...
11 patents (USPTO):Explore Patents

Title: Ofer Lider: Innovator in Immunomodulation and Cytokine Regulation

Introduction: Ofer Lider is a distinguished inventor based in Kfar Bilu, Israel, known for his significant contributions to the fields of immunology and therapeutic development. With a total of 11 patents to his name, Lider's work focuses on innovative approaches to modulate immune responses and tackle autoimmune disorders.

Latest Patents: One of Lider's latest patents centers on HSP60 and its peptides, specifically peptide p277, which plays a crucial role in the modulation of immune responses and inflammatory diseases. This invention explores novel applications for HSP60 in the treatment and prevention of hepatic disorders. It includes methods for treating and alleviating symptoms of T cell-mediated inflammatory and autoimmune disorders through the administration of compositions containing HSP60 and its derivatives.

Additionally, Lider has contributed to the regulation of cytokine activity through compositions comprising carboxylated and/or sulfated oligosaccharides. This patent reveals methods for selectively inhibiting or augmenting the secretion of Tumor Necrosis Factor Alpha (TNF-α), thereby providing pharmaceutical compositions aimed at treating pathological processes associated with cytokine secretion.

Career Highlights: Ofer Lider is associated with Yeda Research and Development Company Limited, where he leverages his expertise in immunology to innovate groundbreaking treatments. His research has the potential to transform approaches to chronic inflammatory conditions and enhance patient care.

Collaborations: Throughout his career, Lider has collaborated with notable scientists, including Irun R. Cohen and Rami Hershkovitz. These partnerships have been pivotal in advancing research in immune system modulation and developing effective therapeutic strategies for autoimmune disorders.

Conclusion: Ofer Lider's impressive portfolio of patents and collaborative work positions him as a key figure in the field of immunology. His inventions not only provide insights into the mechanisms of immune modulation but also offer promising avenues for treating challenging health conditions. As research continues to evolve, Lider's contributions will likely play a crucial role in shaping future therapeutic innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…